According to Adverum Biotechnologies
's latest financial reports the company has a price-to-book ratio of 2.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.9112 | 186.18% |
2022-12-31 | 0.3184 | -41.72% |
2021-12-31 | 0.5464 | -77.56% |
2020-12-31 | 2.43 | -45.08% |
2019-12-31 | 4.43 | 349.64% |
2018-12-31 | 0.9860 | 15.1% |
2017-12-31 | 0.8566 | 52.66% |
2016-12-31 | 0.5611 | -42.42% |
2015-12-31 | 0.9746 | -88.14% |
2014-12-31 | 8.22 | |
2013-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.71 | 32.28% | ๐บ๐ธ USA |